Mochamad Yusuf Alsagaff, - and Hendri Susilo, - (2021) Diuretic Resistance Management in a Patient with Type I Cardiorenal Syndrome: A Case Report. Indian Journal of Forensic Medicine & Toxicology, 15 (3). ISSN 0973-9122

	Text (Artikel) 25. Diuretic Resistance Management in a Patient with Type I Cardiorenal Syndrome A Case Report_Indian Journal of Forensic Medicine & Toxicology 2021.pdf Download (845kB)
	Text (Peer Review) karil 25.pdf Download (94kB)
	Text (Similariti) 25. Turnitin.pdf Download (1MB)

Abstract

Diuretic resistance is commonly found as a problem in acute heart failure (AHF). A further understanding of diuretic response could lead to improved personal approaches for treating patients with AHF. A 48 yo male suffered shortness of breath with a history of hypertension and DM. The patient was diagnosed as Ischemic Cardiomyopathy with Type I Cardiorenal Syndrome. The patient was given a 40 mg continued by 80 mg intravenous furosemide and low dose dobutamine pump. As the patient had zero urine production, a 160 mg intravenous furosemide followed by 15 mg/hr. After high-dose furosemide was given, the urine production was increased and the patient showed improved signs and symptoms. Deteriorating kidney function and bad response to diuretics is a principal clinical problem in AHF. Some treatment strategies include a combination of diuretic therapy, an increased dose of intravenous loop diuretics, and ultrafiltration. However, this patient gave good respond only to high doses of loop diuretics.

Actions (login required)

View Item